The understanding of hepatic fibrosis has expanded dramatically in recent years, leading to
realistic hopes for treating this scarring response to chronic liver disease. Hepatic fibrosis
was once viewed as an esoteric topic of uncertain relevance to clinicians, but it has now
become a dynamic and clinically vital component of assessing patients with ongoing liver
injury. In view of this progress, a review outlining the cellular mechanisms of liver fibrosis
and emerging therapies is highly timely and relevant to clinicians, investigators and trainees …